Sort   by:  
 Page size 
UnknownRituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial.
Not available
S-EPMC3815173 | biostudies-literature
UnknownA randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma.
Not available
S-EPMC3825302 | biostudies-literature
UnknownHigh total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Not available
S-EPMC7162688 | biostudies-literature
UnknownClinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Not available
S-EPMC2343588 | biostudies-literature
Sort   by:  
 Page size